TITLE

When to Begin Highly Active Antiretroviral Therapy? Evidence Supporting Initiation of Therapy at CD4 + Lymphocyte Counts <350 cells/µµ L

AUTHOR(S)
Kaplan, Jonathan E.; Hanson, Debra L.; Cohn, David L.; Karon, John; Buskin, Susan; Thompson, Melanie; Fleming, Patricia; Dworkin, Mark S.
PUB. DATE
October 2003
SOURCE
Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, p951
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Assesses the risk of AIDS-related opportunistic illness or death among persons first prescribed highly active antiretroviral therapy in the U.S. Increase of HIV plasma RNA levels; Improvement of the quality of life of HIV-infected persons; Cause of the decrease of CD4[sup +] lymphocyte counts.
ACCESSION #
11041681

 

Related Articles

  • Maintaining Patients on a Failing Antiretroviral Regimen Reduces the Risk of AIDS-defining Events. Winslow, Dean L. // Infectious Disease Alert;Mar2009, Vol. 28 Issue 6, p28 

    For this study, 12,765 patients from the large French Hospital Database for HIV with CD4+ lymphocyte counts < 200 cells/uL who received cART during 2000-2005 were selected. Three groups of patients were identified: patients who interrupted cART at least once, patients with detectable HIV RNA...

  • HIV-1 Plasma RNA level and CD4 cell count in a large urban HIV-1-infected patient population from 1997 to 2000. Shan, Hua; Piwowar-Manning, Estelle; Thompson, Richard E.; Brooks Jackson, J. // International Journal of STD & AIDS;Nov2003, Vol. 14 Issue 11, p740 

    We evaluated the change in plasma HIV-1 RNA level and CD4 cell counts in an HIV-1-infected population between 1997 and 2000. Both the mean and the median values of plasma HIV-1 RNA level decreased with time with the exception of 1998. The mean and medians for CD4 cell count appear to be fairly...

  • CD28-Negative CD4+ and CD8+ T Cells in Antiretroviral Therapy–Naive HIV-Infected Adults Enrolled in Adult Clinical Trials Group Studies. Tassiopoulos, Katherine; Landay, Alan; Collier, Ann C.; Connick, Elizabeth; Deeks, Steven G.; Hunt, Peter; Lewis, Dorothy E.; Wilson, Cara; Bosch, Ronald // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 11, p1730 

    Background Individuals infected with human immunodeficiency virus (HIV) have higher risk than HIV-negative individuals for diseases associated with aging. T-cell senescence, characterized by expansion of cells lacking the costimulatory molecule CD28, has been hypothesized to mediate these risks....

  • HAART-Persistent HIV-1 Latent Reservoirs: Their Origin, Mechanisms of Stability and Potential Strategies for Eradication. Kulkosky, Joseph; Bray, Stacie // Current HIV Research;Apr2006, Vol. 4 Issue 2, p199 

    HIV-1 infection persists despite long-term administration of highly active antiretroviral therapy (HAART). The mechanism of this persistence appears to result primarily from viral infection of CD4+ T-lymphocytes that have the ability to duplicate and revert into a quiescent state. These infected...

  • Étude pilote de la thérapie antirétrovirale à Djibouti. Ahmed, A. A.; Latoundji, S. // Eastern Mediterranean Health Journal;nov/dec2007, Vol. 13 Issue 6, p1274 

    A cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for > 3 months to assess the efficacy of treatment (viral load < 400 copies/mL). The median age at enrolment was 36 years, 90% of patients were at the AIDS stage and median CD4 rate was...

  • CD8+ Cell Noncytotoxic Antiviral Response in Long-Term HIV-1 Infected Former Blood Donors in China. Lin Yuan; Liying Ma; Xiujuan Fan; Yi Feng; Hong Peng; Quanbi Zhao; Yuhua Ruan; Levy, J. A.; Yiming Shao // Current HIV Research;Jul2009, Vol. 7 Issue 4, p437 

    Most of the HIV-infected long term survivors show strong CD8+ cell noncytotoxic antiviral response (CNAR) that plays as an important factor for maintaining the relative healthy state of infected individuals. HIV infected former blood donors (FBDs) in Anhui, China are the unique population that...

  • CD4+ Count—Guided Interruption of Antiretroviral Treatment.  // New England Journal of Medicine;11/30/2006, Vol. 355 Issue 22, p2283 

    Background: Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of the human immunodeficiency virus (HIV). Methods: We randomly assigned persons infected with HIV...

  • Antivirograma, sensible, rápido y fácil de interpretar por un método de bioluminiscencia para el VIH-1. Lara, H. H.; Ixtepan-Turrent, L.; Rivera-Silva, G.; González-Salazar, F.; Moreno-Treviño, G. // Revista Latinoamericana de Patología Clínica y Medicina de Lab;abr-jun2013, Vol. 60 Issue 2, p79 

    Objective: To demonstrate that our assay is sensitive capable to detect 10 HIV infected cells per well and that is feasible to quantify HIV-1 resistance in seropositive patients. Method: To compare 3 different phenotypic assays by quantifying their sensitivities, first we co-cultivated...

  • Persistence of HIV in Gut-associated Lymphoid Tissue with Antiretroviral Therapy. Winslow, Dean L. // Infectious Disease Alert;May2008, Vol. 27 Issue 8, p85 

    Eight HIV-infected patients (mean cd4+ T cell count 622 cells/uL) who had been receiving effective HAART for an average of 8.4 years were included in this study. PBMCs were obtained by leukapheresis and endoscopic terminal ileum biopsies were performed to obtain samples of Gut-Associated...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics